| Gene symbol | CD70 | Synonyms | CD27-L, CD27L, CD27LG, LPFS3, TNFSF7, TNLG8A | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19p13.3 | dbXrefs | |
| Description | CD70 molecule | ||||
| GTO ID | GTC1624 |
| Trial ID | NCT02830724 |
| Disease | Breast Cancer | Melanoma | Renal Carcinoma | Ovarian Cancer | Pancreatic Cancer |
| Altered gene | CD70 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD70 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers |
| Year | 2017 |
| Country | United States |
| Company sponsor | National Cancer Institute (NCI) |
| Other ID(s) | 160131|16-C-0131 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||
|
|||||||||||